×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
LMAT – lemaitre vascular, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
LMAT
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/6
11:09 pm
lmat
LeMaitre Vascular, Inc. (NASDAQ: LMAT) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Low
Report
LeMaitre Vascular, Inc. (NASDAQ: LMAT) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
11/2
09:29 am
lmat
LeMaitre Vascular Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
Low
Report
LeMaitre Vascular Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
11/1
05:23 pm
lmat
LeMaitre Vascular declares $0.16 dividend [Seeking Alpha]
Low
Report
LeMaitre Vascular declares $0.16 dividend [Seeking Alpha]
11/1
04:47 pm
lmat
LeMaitre to Participate at Upcoming Investor Conferences in November
Low
Report
LeMaitre to Participate at Upcoming Investor Conferences in November
11/1
01:38 pm
lmat
LeMaitre Vascular, Inc. (NASDAQ: LMAT) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $93.00 price target on the stock, up previously from $90.00.
Medium
Report
LeMaitre Vascular, Inc. (NASDAQ: LMAT) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $93.00 price target on the stock, up previously from $90.00.
11/1
11:56 am
lmat
LeMaitre Vascular, Inc. (NASDAQ: LMAT) had its price target raised by analysts at Barrington Research from $92.00 to $93.00. They now have an "outperform" rating on the stock.
Medium
Report
LeMaitre Vascular, Inc. (NASDAQ: LMAT) had its price target raised by analysts at Barrington Research from $92.00 to $93.00. They now have an "outperform" rating on the stock.
10/31
08:35 pm
lmat
LeMaitre Vascular (LMAT) Surpasses Q3 Earnings and Revenue Estimates [Yahoo! Finance]
Medium
Report
LeMaitre Vascular (LMAT) Surpasses Q3 Earnings and Revenue Estimates [Yahoo! Finance]
10/31
04:05 pm
lmat
LeMaitre Q3 2024 Financial Results
Medium
Report
LeMaitre Q3 2024 Financial Results
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/19
06:05 pm
lmat
Form 4 LEMAITRE VASCULAR INC For: Nov 15 Filed by: Ross Bridget A
Low
Report
Form 4 LEMAITRE VASCULAR INC For: Nov 15 Filed by: Ross Bridget A
11/19
05:48 pm
lmat
Form 4 LEMAITRE VASCULAR INC For: Nov 15 Filed by: O'Connor John James
Low
Report
Form 4 LEMAITRE VASCULAR INC For: Nov 15 Filed by: O'Connor John James
11/15
05:25 pm
lmat
Form 144 LEMAITRE VASCULAR INC Filed by: Ross Bridget A
Low
Report
Form 144 LEMAITRE VASCULAR INC Filed by: Ross Bridget A
11/15
05:02 pm
lmat
Form 4 LEMAITRE VASCULAR INC For: Nov 13 Filed by: SHADAN MARTHA
Low
Report
Form 4 LEMAITRE VASCULAR INC For: Nov 13 Filed by: SHADAN MARTHA
11/13
06:29 pm
lmat
Form 144 LEMAITRE VASCULAR INC Filed by: SHADAN MARTHA
Low
Report
Form 144 LEMAITRE VASCULAR INC Filed by: SHADAN MARTHA
11/13
04:59 pm
lmat
Form 4 LEMAITRE VASCULAR INC For: Nov 11 Filed by: LeMaitre George W
Low
Report
Form 4 LEMAITRE VASCULAR INC For: Nov 11 Filed by: LeMaitre George W
11/8
05:37 pm
lmat
Form SC 13G/A LEMAITRE VASCULAR INC Filed by: BlackRock, Inc.
Low
Report
Form SC 13G/A LEMAITRE VASCULAR INC Filed by: BlackRock, Inc.
11/8
11:32 am
lmat
Form 10-Q LEMAITRE VASCULAR INC For: Sep 30
Low
Report
Form 10-Q LEMAITRE VASCULAR INC For: Sep 30
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/23
Form 4 LEMAITRE VASCULAR INC For: Mar 19 Filed by: LeMaitre George W
9.6%
4/6 LeMaitre Vascular Inc (NASDAQ: LMAT) had its price target lowered by analysts at Lake Street Capital from $40.00 to $28.00. They now have a "buy" rating on the stock. 6.1%
4/13 LeMaitre Vascular Withdraws Prior Annual Guidance for 2020 And Announces Preliminary Q1 2020 Financial Results 3.8%
7/20 LeMaitre Vascular Inc (NASDAQ: LMAT) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. 3.6%
10/13 LeMaitre Vascular Acquires Biologic Patch Business from Admedus 3.4%
9/9 Form 4 LEMAITRE VASCULAR INC For: Sep 05 Filed by: LeMaitre George W 3.2%
10/22 Form 4 LEMAITRE VASCULAR INC For: Oct 18 Filed by: Roberts David B 3.1%
7/22 LeMaitre Vascular Inc (NASDAQ: LMAT) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. 3.0%
7/17 Form 4 LEMAITRE VASCULAR INC For: Jul 16 Filed by: O'Connor John James 2.8%
2/11 LeMaitre Vascular Inc (NASDAQ: LMAT) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $33.00 price target on the stock. 2.8%
4/6 LeMaitre Vascular Inc (NASDAQ: LMAT) had its price target lowered by analysts at Lake Street Capital from $40.00 to $28.00. They now have a "buy" rating on the stock. 6.1%
4/13 LeMaitre Vascular Withdraws Prior Annual Guidance for 2020 And Announces Preliminary Q1 2020 Financial Results 3.8%
7/20 LeMaitre Vascular Inc (NASDAQ: LMAT) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. 3.6%
10/13 LeMaitre Vascular Acquires Biologic Patch Business from Admedus 3.4%
9/9 Form 4 LEMAITRE VASCULAR INC For: Sep 05 Filed by: LeMaitre George W 3.2%
10/22 Form 4 LEMAITRE VASCULAR INC For: Oct 18 Filed by: Roberts David B 3.1%
7/22 LeMaitre Vascular Inc (NASDAQ: LMAT) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. 3.0%
7/17 Form 4 LEMAITRE VASCULAR INC For: Jul 16 Filed by: O'Connor John James 2.8%
2/11 LeMaitre Vascular Inc (NASDAQ: LMAT) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $33.00 price target on the stock. 2.8%
TOP News Decliners
2/6
Form 8-K LEMAITRE VASCULAR INC For: Feb 06
-19.5%
3/12 Form 10-K LEMAITRE VASCULAR INC For: Dec 31 -18.1%
3/16 LeMaitre Vascular Inc (NASDAQ: LMAT) was upgraded by analysts at Sidoti from a "neutral" rating to a "buy" rating. They now have a $38.00 price target on the stock. -9.7%
7/25 LeMaitre Vascular Inc (NASDAQ: LMAT) had its price target raised by analysts at Barrington Research from $32.00 to $37.00. They now have an "outperform" rating on the stock. -8.7%
4/30 Q1/2020 3/31/2020 EPS 0.160 ZacksConsensus 0.160 ActVsEst 0.000 - In-Line -7.4%
4/30 LeMaitre Vascular Inc (NASDAQ: LMAT) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -7.2%
4/17 Form 8-K LEMAITRE VASCULAR INC For: Apr 13 -5.6%
4/21 LeMaitre Vascular Inc (NASDAQ: LMAT) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -5.5%
10/23 Q3/2019 9/30/2019 EPS 0.250 ZacksConsensus 0.210 ActVsEst 0.040 - Beat -4.5%
11/5 Form 4 LEMAITRE VASCULAR INC For: Nov 01 Filed by: LeMaitre George W -4.2%
3/12 Form 10-K LEMAITRE VASCULAR INC For: Dec 31 -18.1%
3/16 LeMaitre Vascular Inc (NASDAQ: LMAT) was upgraded by analysts at Sidoti from a "neutral" rating to a "buy" rating. They now have a $38.00 price target on the stock. -9.7%
7/25 LeMaitre Vascular Inc (NASDAQ: LMAT) had its price target raised by analysts at Barrington Research from $32.00 to $37.00. They now have an "outperform" rating on the stock. -8.7%
4/30 Q1/2020 3/31/2020 EPS 0.160 ZacksConsensus 0.160 ActVsEst 0.000 - In-Line -7.4%
4/30 LeMaitre Vascular Inc (NASDAQ: LMAT) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -7.2%
4/17 Form 8-K LEMAITRE VASCULAR INC For: Apr 13 -5.6%
4/21 LeMaitre Vascular Inc (NASDAQ: LMAT) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -5.5%
10/23 Q3/2019 9/30/2019 EPS 0.250 ZacksConsensus 0.210 ActVsEst 0.040 - Beat -4.5%
11/5 Form 4 LEMAITRE VASCULAR INC For: Nov 01 Filed by: LeMaitre George W -4.2%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: